A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized

Linda G Park1, Jill Howie-Esquivel2, Misook L Chung3

  • 1San Francisco VA Medical Center, Division of Geriatrics, Palliative and Extended Care, USA.

Insights

Text messages (TM) improved adherence to antiplatelet medications in coronary heart disease patients. This mobile health intervention shows promise for enhancing medication adherence and secondary prevention.

Area of Science:

  • Cardiology
  • Digital Health
  • Pharmacology

Background:

  • Secondary prevention of coronary heart disease (CHD) is crucial for patient outcomes.
  • Adherence to antiplatelet and statin therapy is vital for managing CHD.
  • Mobile health interventions offer novel approaches to improve patient adherence.

Purpose of the Study:

  • To compare antiplatelet and statin adherence in patients with CHD receiving different text message (TM) interventions.
  • To evaluate the impact of medication reminders and education via TM on adherence.
  • To assess the feasibility and satisfaction of a mobile health intervention for CHD patients.

Main Methods:

  • A randomized controlled trial involving 90 CHD patients over 30 days.
  • Utilized electronic monitoring (Medication Event Monitoring System - MEMS) to assess adherence.
  • Analyzed adherence data using ANOVA and t-tests; self-reported adherence via Morisky Medication Adherence Scale.

Main Results:

  • Patients receiving TM for antiplatelets showed significantly higher correct dose administration and adherence on schedule (p<0.05).
  • TM response rates were higher for antiplatelets compared to statins (p=0.005).
  • No significant differences in self-reported adherence were observed between groups.

Conclusions:

  • Text message interventions significantly improved adherence to antiplatelet therapy, as confirmed by MEMS and TM response rates.
  • Mobile health interventions are feasible, well-tolerated, and demonstrate potential for enhancing medication adherence in CHD management.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753